Novo CEO pressed by Senate to chop costs of weight problems, diabetic issues prescription drugs CEO Lars Fruergaard Jørgensen informed lawmakers the organization would look at new talks with insurers about the list rates of Wegovy and copyright when they pledge to help keep the medicines on their own formularies. https://rafaelzpfwl.blog-mall.com/31227968/about-healthcare-news